Payment overview · 2025
General Payments
$21.87
1 reported records · 1 companies
Healthcare provider profile · identity verified
Chaitya Parikh, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · BLAIRSVILLE, PA · NPI 1740775253
Verified facts
What the public records show
CMS Open Payments records show Chaitya Parikh, D.O. received $21.87 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $21.87 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.87 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN Normalized: watchman |
Device | Boston Scientific Corporation | $21.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 427 | 100 |
| Atorvastatin Calcium | Atorvastatin Calcium | 421 | 127 |
| Lisinopril | Lisinopril | 326 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 301 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 292 | 77 |
| Simvastatin | Simvastatin | 285 | 68 |
| Furosemide | Furosemide | 261 | 61 |
| Metformin Hcl | Metformin Hcl | 258 | 78 |
| Tamsulosin Hcl | Tamsulosin Hcl | 219 | 63 |
| Omeprazole | Omeprazole | 217 | 60 |
| Metoprolol Succinate | Metoprolol Succinate | 196 | 49 |
| Prednisone | Prednisone | 196 | 95 |
| Gabapentin | Gabapentin | 195 | 45 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 163 | 60 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 162 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 159 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 157 | 41 |
| Xarelto | Rivaroxaban | 144 | 25 |
| Famotidine | Famotidine | 143 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 143 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 126 | 29 |
| Lorazepam | Lorazepam | 124 | 30 |
| Losartan Potassium | Losartan Potassium | 121 | 36 |
| Jardiance | Empagliflozin | 116 | 31 |
| Montelukast Sodium | Montelukast Sodium | 111 | 29 |
| Trazodone Hcl | Trazodone Hcl | 107 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 106 | 32 |
| Potassium Chloride | Potassium Chloride | 106 | 37 |
| Eliquis | Apixaban | 98 | 20 |
| Pregabalin | Pregabalin | 84 | 14 |
| Sertraline Hcl | Sertraline Hcl | 84 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 33 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 80 | 19 |
| Irbesartan | Irbesartan | 79 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 78 | 65 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 19 |
| Ozempic | Semaglutide | 76 | 15 |
| Ondansetron Odt | Ondansetron | 72 | 25 |
| Finasteride | Finasteride | 71 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 23 |
| Meloxicam | Meloxicam | 70 | 27 |
| Tramadol Hcl | Tramadol Hcl | 68 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 66 | 22 |
| Ezetimibe | Ezetimibe | 65 | 12 |
| Cephalexin | Cephalexin | 64 | 34 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 16 |
| Metformin Hcl Er | Metformin Hcl | 63 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 62 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 60 | 18 |
| Buspirone Hcl | Buspirone Hcl | 58 | 18 |
| Meclizine Hcl | Meclizine Hcl | 58 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 57 | 38 |
| Allopurinol | Allopurinol | 54 | 16 |
| Azithromycin | Azithromycin | 54 | 45 |
| Carvedilol | Carvedilol | 53 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 52 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 49 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | 17 |
| Alprazolam | Alprazolam | 45 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 17 |
| Bupropion Xl | Bupropion Hcl | 42 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 42 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 41 | 11 |
| Farxiga | Dapagliflozin Propanediol | 40 | suppressed |
| Mirtazapine | Mirtazapine | 40 | 11 |
| Spironolactone | Spironolactone | 39 | 13 |
| Baclofen | Baclofen | 38 | 11 |
| Betamethasone Valerate | Betamethasone Valerate | 38 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Atenolol | Atenolol | 36 | 14 |
| Ibuprofen | Ibuprofen | 36 | 11 |
| Synthroid | Levothyroxine Sodium | 36 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 35 | suppressed |
| Methylprednisolone | Methylprednisolone | 35 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 32 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 27 |
| Tradjenta | Linagliptin | 31 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 31 | suppressed |
| Linzess | Linaclotide | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | 11 |
| Fluconazole | Fluconazole | 29 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | 11 |
| Naproxen | Naproxen | 28 | 11 |
| Valsartan | Valsartan | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | 11 |
| Ranolazine Er | Ranolazine | 22 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 13 |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 11 |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Glimepiride | Glimepiride | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Nateglinide | Nateglinide | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Epinephrine | Epinephrine | 12 | 11 |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 12 | suppressed |
| Victoza 3-Pak | Liraglutide | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.87 · 1 records | Boston Scientific Corporation | WATCHMAN | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error